Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-20-033102

Director bought 10,000 shares at $0.90 ($9,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Basenese Lou Director 2020-05-29 Purchase +10,000 $0.90 $9,000 99,068 D
Open-market purchases · 10,000 sh · avg $0.90 · $9,000
Loading xslF345X03/doc4.xml…